Apr 4, 2021

#41 - Africa, B.1.1.7, Alzheimer, Google

Issue #41 — View online — Suggest a link

Health

The latest news and information about innovations in healthcare.

Hi friends! 👋

I hope this email finds you well. Welcome to the 20 new subscribers ✨

Please find below some highlights regarding four subjects I think could interest you: vaccine development in Africa (and what it says about global healthcare innovation), the B.1.1.7 variant in the US, updates on Alzheimer’s research and an interesting new Google Scholar feature.

Hope you’ll enjoy 😊

Have a good week,

Alaedine Benani - MD PhD Trainee

Why does Africa not have its own Covid-19 vaccine? — Quartz Africa

Middle-income countries across the world have vaccines in human clinical trials. Why hasn’t the same happened in Africa?

Read now | Share

Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States: Cell

Genomic epidemiology analyses explain the introduction and transmission of the B.1.1.7 variant of SARS-CoV-2 into the United States, with projections for it to soon be the dominant strain in the country.

Read now | Share

Antibody therapies for Parkinson’s and Alzheimer’s may cause harmful inflammation | Scripps Research

Scientists find evidence that antibody-based treatments in clinical trials for neurodegenerative diseases may trigger an inflammatory response in human brain immune cells, eroding their positive effects.

Read now | Share

Do you obey public-access mandates? Google Scholar is watching

Search-engine co-founder Anurag Acharya explains why it now tells authors when their papers should be made free to read.

Read now | Share

Techstars Startup Digest Health is curated by:

Alaedine Benani - MD PhD Trainee - MSc in Data Science & Entrepreneurship
alaedine.benani@startupdigestmail.com

Did you enjoy this issue?

Did you see something you think we should include in our newsletter? Suggest a link.

Manage all your newsletter subscriptions here.

If you were forwarded this newsletter and you like it, you can subscribe here.

If you don’t want to receive this newsletter anymore, unsubscribe here.